ArticleVascular specialist international2026
Intravascular Lithotripsy-Assisted Stenting of Supraceliac Coral Reef Aorta Using a Partially Deployed WALLSTENT for Temporary Embolic Protection: A Case Report.
Article in Vascular specialist international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coral reef aorta (CRA) is characterized by dense, rock-hard intraluminal calcified plaques that can cause critical aortic stenosis or occlusion. We report the case of a 59-year-old man who presented with accelerated hypertension, acute decompensated heart failure, bilateral pleural effusions, acute kidney injury, adrenal insufficiency, and progressive inability to ambulate. Computed tomography angiography demonstrated a near-occlusive supraceliac CRA lesion with markedly reduced infraceliac aortic flow. The lesion was successfully treated with intravascular lithotripsy-assisted stenting, During the procedure, a partially deployed WALLSTENT (Boston Scientific) was used for temporary distal embolic protection. The postoperative course was uneventful, with resolution of heart failure, normalization of renal function, improvement in adrenal function, and reduction in antihypertensive requirements from four to two agents. The patient remained asymptomatic at the 6-month follow-up. This case suggests that endovascular management using intravascular lithotripsy-assisted stenting with temporary WALLSTENT-based embolic protection may be feasible for selected patients with complex supraceliac CRA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.